Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Pagliardini T, Castagna L, Harbi S, Porta MD, Rey J, Fürst S, Bramanti S, Saillard C, Legrand F, Maisano V, Faucher C, Granata A, Hospital MA, Lining W, Weiller PJ, Calmels B, Charbonnier A, Lemarie C, Chabannon C, Vey N, Mokart D, Blaise D, Devillier R. Pagliardini T, et al. Among authors: faucher c. Biol Blood Marrow Transplant. 2019 Sep;25(9):1803-1809. doi: 10.1016/j.bbmt.2019.05.014. Epub 2019 May 22. Biol Blood Marrow Transplant. 2019. PMID: 31128325 Free article. Clinical Trial.
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.
Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O, Vey N, Stoppa AM, Coso D, Chabannon C, Viens P, Maraninchi D, Blaise D. Mohty M, et al. Among authors: faucher c. Blood. 2003 Jul 15;102(2):470-6. doi: 10.1182/blood-2002-12-3629. Epub 2003 Mar 20. Blood. 2003. PMID: 12649133 Free article.
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Blaise D, Farnault L, Faucher C, Marchetti N, Fürst S, El Cheikh J, Ladaique P, Vey N, Bouabdallah R, Stoppa AM, Lemarie C, Calmels B, Prebet T, Castagna L, Chabannon C, Mohty M, Esterni B. Blaise D, et al. Among authors: faucher c. Exp Hematol. 2010 Dec;38(12):1241-50. doi: 10.1016/j.exphem.2010.08.012. Epub 2010 Sep 17. Exp Hematol. 2010. PMID: 20850502
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma.
El-Cheikh J, Crocchiolo R, Furst S, Ladaique P, Castagna L, Faucher C, Granata A, Oudin C, Lemarie C, Calmels B, Stoppa AM, Schiano De Colella JM, Duran S, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: faucher c. Exp Hematol. 2012 Jul;40(7):521-7. doi: 10.1016/j.exphem.2012.02.009. Epub 2012 Mar 23. Exp Hematol. 2012. PMID: 22446605 Free article. Clinical Trial.
Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
El-Cheikh J, Vazquez A, Crocchiolo R, Furst S, Calmels B, Castagna L, Lemarie C, Granata A, Ladaique P, Oudin C, Faucher C, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: faucher c. Am J Hematol. 2012 Dec;87(12):1074-8. doi: 10.1002/ajh.23319. Epub 2012 Aug 22. Am J Hematol. 2012. PMID: 22911907 Free article.
Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience.
El-Cheikh J, Crocchiolo R, Furst S, Ladaique P, Castagna L, Faucher C, Calmels B, Oudin C, Lemarie C, Granata A, Devillier R, Vey N, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: faucher c. Exp Hematol. 2013 Jan;41(1):17-27. doi: 10.1016/j.exphem.2012.09.008. Epub 2012 Sep 25. Exp Hematol. 2013. PMID: 23022128
Response to immunosuppressive treatment predicts outcome in patients with chronic graft-versus-host disease: a single-center analysis of longitudinal data.
Crocchiolo R, Saillard C, Signori A, Fürst S, El Cheikh J, Castagna L, Oudin C, Granata A, Faucher C, Devillier R, Crocchiolo D, Sormani MP, Chabannon C, Blaise D. Crocchiolo R, et al. Among authors: faucher c. Biol Blood Marrow Transplant. 2013 Apr;19(4):576-83. doi: 10.1016/j.bbmt.2012.12.016. Epub 2012 Dec 25. Biol Blood Marrow Transplant. 2013. PMID: 23270984 Free article.
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J, Crocchiolo R, Furst S, Stoppa AM, Ladaique P, Faucher C, Calmels B, Lemarie C, De Colella JM, Granata A, Coso D, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: faucher c. Am J Hematol. 2013 May;88(5):370-4. doi: 10.1002/ajh.23412. Epub 2013 Mar 5. Am J Hematol. 2013. PMID: 23460414 Free article.
239 results